Guardant Health, Inc.·4

Jul 2, 6:13 PM ET

Saia John G. 4

Research Summary

AI-generated summary

Updated

Guardant Health (GH) Chief Legal Officer John Saia Exercises RSUs

What Happened

  • John G. Saia, Chief Legal Officer of Guardant Health, had restricted stock units convert into 7,063 shares on July 1, 2026. The company withheld 3,707 shares to satisfy tax withholding at $170.77 per share (total value withheld: $633,044), leaving a net 3,356 shares delivered to Mr. Saia. This was a vesting/tax-withholding event, not an open-market sale.

Key Details

  • Transaction date: July 1, 2026; Form 4 filed July 2, 2026 (timely).
  • Acquired: 7,063 shares via exercise/conversion of RSUs (transaction code M).
  • Withheld/disposed for taxes: 3,707 shares at $170.77/share, value $633,044 (transaction code F; footnote F1 explains company retained shares to meet tax withholding).
  • Net shares retained by insider from this vesting: 3,356 (7,063 vested − 3,707 withheld).
  • Relevant awards: RSUs from grants on 11/7/2022, 12/13/2023, 11/8/2024, and 3/12/2025 with multi-year vesting schedules (see footnotes F2–F6).
  • Post-transaction total beneficial ownership not included in the provided excerpt.

Context

  • This was a routine RSU vesting with share withholding to cover taxes (common practice), not an open-market sale or purchase. Transaction codes: M = exercise/conversion of derivative (RSU vesting here), F = payment of tax liability via share withholding. Such withholding transactions generally reflect compensation tax mechanics rather than a change in insider sentiment.